IL-15 is more effective in upregulating the expression of NKp46 and NKp30, which are involved in the recognition and killing of tumor- and virus-infected cells; IL-15 also increases the CD69 expression, which is an early activation marker on T and NK cells [85, 86]. The gene discussed is IL15; the disease is neoplasm.